TIF News
-
TIF and EHA Explore How COVID-19 Is Affecting Thalassemia & SCD Patients
On 16 April, TIF and the European Hematology Association (EHA) successfully organised a highly interactive webinar entitled ”Thalassaemia/SCD and COVID-19: Possible risks and a proposal for a patient pathway during…
Read More » -
NOW ONLINE: TIF’s latest Informational Guide on Developing Vaccinations & Therapeutic Drugs for COVID-19
TIF has made an effort to put together a list of studies/clinical trials for treatments and vaccines about COVID-19, which is by no means exhaustive as this situation is ever-changing…
Read More » -
“Now I Am The Voice“: A journey of self‐discovery through the eyes of a Thalassaemic
TIF’s Expert Patient and long-standing collaborator and friend, Maria Hadjidemetriou, shares her inspiring and thought-provoking journey with thalassaemia and reflects on the lessons it has taught her. Click on the…
Read More » -
Revisiting WHO Guidance Document on the Protection of Blood Supplies developed with TIF’s contribution
In an effort to assist national blood services in the development of plans to respond to any emerging infectious threats, as far as the sufficiency or safety of the…
Read More » -
Novavax to start human trial for ‘ideal’ coronavirus vaccine candidate
The biotech company Novavax announced today that it has identified an “ideal” coronavirus vaccine candidate — and is set to launch the first clinical human trial in mid-May. The candidate,…
Read More » -
IMPORTANT ANNOUNCEMENT: TIF reschedules the International Thalassaemia Day 2020 Celebrations for the 8th of September due to coronavirus
Given the unprecedented global public health crisis brought on by the COVID-19 pandemic, TIF announces that the celebrations of the International Thalassaemia Day 2020 on the 8th of May, including…
Read More » -
TIF publishes new material on the COVID-10 Pandemic
TIF continues the efforts to address the questions and concerns of its global patients’ and healthcare professionals’ community about the COVID-19 Pandemic and, in doing so, it has issued 2…
Read More » -
The changing epidemiology of the ageing thalassaemia populations: A new position statement by TIF
Therapeutic advances in β-thalassaemia have gradually led to a significant improvement in prognosis over the past few decades. As a result, patients living in areas where disease specific programmes offer…
Read More » -
TIF’s enriched Leaflet ”The COVID-19 Pandemic & Haemoglobin Disorders” is available today!
During these difficult and challenging times the coronavirus (COVID-19) pandemic is creating at a global level, individuals with underlying medical conditions, such as blood disorders, heart disease, chronic liver disease,…
Read More » -
A Useful Health & Nutrition Short Guide for the COVID-19 Pandemic by TIF
The coronavirus presents many uncertainties, and none of us can completely eliminate the risk of getting infected with COVID-19. Nevertheless, one thing we can do is eat as healthy as…
Read More »